Insiders who reported open-market trades in the last 12 months at the companies Alfred J. Ford Jr. files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Alfred J. Ford Jr. is a corporate insider, tracked as Chief Commercial Officer of KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS). InsiderAlpha holds 7 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Alfred J. Ford Jr. submitted recently?
3 primary Form 4 filings in the last 90 days, covering 1 company.
Has Alfred J. Ford Jr. been buying or selling stock?
Recorded transactions: 1 open-market purchase ($340K) and 4 open-market sales ($794K) across all tracked filings.
Alfred J. Ford Jr. is Chief Commercial Officer of KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS). 7 SEC Form 4 filings on record going back to 2024, most recently on 6 August 2026. Most recent open-market trade: sold $151K of KMTS on 6 August 2026. Lifetime open-market purchases: $340K. Lifetime open-market sales: $794K.
Recent transactions
9
The latest 9 SEC Form 4 transactions reported by Alfred J. Ford Jr..
InsiderAlpha's records for Alfred J. Ford Jr. go back to 2024: 7 primary Form 4 filings, an average of 2.3 per year. The typical open-market purchase is $340K (1 buy totaling $340K). The largest single buy on record is $340K of KMTS in 2025. Sales side: 4 recorded sales totaling $794K, so the filing history runs sell-heavy by dollar value. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
